PainChek Limited (ASX:PCK)
0.0340
+0.0010 (2.94%)
Jun 19, 2025, 2:39 PM AEST
PainChek Company Description
PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally.
The company offers PainChek, which uses cameras in smartphones and tablets for a facial scan that is analyzed in real time using facial recognition software to indicate the presence of pain.
It serves patients suffering with dementia and pre-verbal infants; and the aged care, disability, home care, hospital, and infant sectors.
The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018.
PainChek Limited is based in Sydney, Australia.
PainChek Limited

Country | Australia |
Industry | Health Information Services |
Sector | Healthcare |
CEO | Philip Daffas |
Contact Details
Address: 35 Lime Street Sydney, Western Australia 2000 Australia | |
Phone | 61 4 2125 2123 |
Website | painchek.com |
Stock Details
Ticker Symbol | PCK |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU000000PCK6 |
SIC Code | 7372 |
Key Executives
Name | Position |
---|---|
Philip Daffas B.Sc., Dip EENG, GAICD, M.B.A. | MD, Chief Executive Officer and Director |
Iain McAdam | Chief Financial Officer |
Andrew Hoggan | Manager and Head of Operations |
Scott Robertson M.B.A. | Chief Technology Officer |
Prof. Jeff Hughes Ph.D. | Chief Scientific Officer |
David Allsopp | Head of Business Development of North America |
Nick Garofoli | Head of Business Development of USA |
Natalie Sylvia Climo L.L.B. | Company Secretary |